Investing

Three Things You Need in Place Before Starting a 1031 Exchange

Three Things You Need in Place Before Starting a 1031 Exchange

Most investors treat a 1031 exchange as something to figure out after they decide to sell. The property goes on the market, a buyer comes in, and only then does the conversation shift to replacement properties and tax deferral strategies. By that point, the clock is already working against them.

A 1031 exchange has strict timelines and specific requirements, and waiting until the sale is underway to address them is how investors end up either rushing into poor replacement property decisions or losing the exchange entirely.

The smarter approach is to have the critical pieces in place before the listing goes live. A 1031 exchange allows investors to defer capital gains taxes by reinvesting sale proceeds into qualifying 1031 exchange properties within a defined timeframe.

The tax benefit is significant, but only if the foundation is laid early. So, if you are starting a 1031 exchange, this post will discuss three things you need in place.

A Qualified Intermediary Needs To Be Appointed Before Closing

The IRS disqualifies any investor who takes possession of the sale proceeds at any point during a 1031 exchange. If sales funds hit your account, even briefly, the exchange is disqualified. To avoid the situation, you need a qualified intermediary.

What a qualified intermediary does:

  • Holds the proceeds from the sale in a secure account

  • Facilitates the purchase of the replacement property on the investor's behalf

  • Ensures compliance with IRS requirements throughout the exchange

The timing requirement catches investors off guard. The intermediary must be in place before the sale closes. Trying to appoint one after closing, even a day later, invalidates the exchange. This is not a formality that can be handled retroactively.

Investors should vet intermediaries while the property is on the market, not scramble to find one in the final days before closing. It is also important to understand that not all intermediaries are equal. Look for firms with experience, proper bonding, and segregated account structures. Ask the right questions, like how long they have been facilitating exchanges or whether they carry errors and omissions insurance.

The intermediary holds your entire sale proceeds, so vetting them thoroughly is not optional.

At Least One Replacement Property Should Be Identified Early

Once the sale closes, investors have 45 days to formally identify potential replacement properties in writing. That sounds reasonable until the reality of property research, market analysis, and due diligence sets in. Forty-five days is not enough time to start from scratch.

The practical move is to have at least one viable replacement property identified before the original property even sells. This provides a baseline option that meets the requirements and fits the investment strategy. Investors can identify up to three properties of any value during the 45-day window, leaving room to explore other options after the sale.

Delaware Statutory Trusts have become a common solution for investors who want access to institutional-quality properties without taking on direct management. A DST allows fractional ownership in professionally managed assets, and because these properties are pre-identified and structured, they work well for investors working within the 45-day identification window.

Assets available through DST structures include:

  • Large-scale multifamily communities

  • Senior housing facilities across multiple states

  • Net-leased retail backed by national tenants

  • Medical office buildings with long-term triple net leases

These are properties that most individual investors cannot acquire independently, and the DST structure makes them accessible as qualifying 1031 replacement options.

A Tax Advisor Who Knows 1031 Exchanges Specifically

Rules for a 1031 exchange are different and more complex than those for a typical investment property sale. That is why this process requires an expert who specializes in 1031 exchanges. The rules on identification, qualified use, timeline, and replacement property valuation are set in stone, and mistakes cannot be easily corrected.

A tax advisor with 1031 exchange experience should:

  • Ensure the qualification of both the relinquished and replacement property

  • Set up an exchange structure

  • Communicate with intermediaries throughout the process

  • Manage depreciation recapture and basis adjustments

If you are exchanging a property, engage a tax advisor before listing the property, not after the sale closes. If you are still relying on general tax advice, you might run into roadblocks that you regret later.

Conclusion

For investors, a 1031 exchange is golden for deferring taxes and keeping their capital working in real estate. But this cannot work without preparation and seamless execution. It is important to appoint a qualified intermediary before closing, identify replacement properties early, and work with a tax advisor who understands 1031 exchanges like the back of their hand. This will determine whether an exchange goes smoothly or falls apart.

Investors who handle these pieces in advance are the ones who actually benefit from the tax deferral rather than losing it to poor timing or procedural mistakes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading